News
Glaxo, Shionogi Say HIV Drug Beats Gilead Atripla in Test
www.bloomberg.com
[Bloomberg] - The results mean peak sales may reach $5 billion, double an earlier estimate, James Gordon, an analyst at JPMorgan Chase & Co., said in a report. He raised his estimate of the probability of regulatory approval to 100 percent from 50 percent.
Aviva in favour as market flatlines
www.telegraph.co.uk
[Telegraph.co.uk] - JP Morgan analyst James Gordon said the news was “unexpected” and boosted the probability the drug would get regulatory approval to 100pc from 50pc. Glaxo's product could be filed for approval by the end of the year and may well prove lucrative for the
Winston Packaging Invests in a KBA Rapida " Six-Color
whattheythink.com
[What They Think] we are completing the largest equipment upgrade in our history with the centerpiece being a new KBA Rapida inch press, as well as a new CTP device and a new 106 Bobst die-cutter,” says James Gordon, president and CEO of Winston Packaging.
Google News: Solo un héroe podrá rescatarnos
[Milenio.com] - Somos nosotros, esto es Ciudad Gótica y usted, ese empresario, ese político, ese delincuente y hasta yo podemos ser 'Bruce Wayne', 'Carmine Falcone', 'Jonathan Crane', 'James Gordon', 'el Guasón', 'Harvey Dent' o 'Selina Kyle'. ¿En qué va a terminar
sorted by relevance / date